Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    Abschluss Der Revision Des Heilmittelgesetzes

    In der Frühjahrsession 2016 wurde das revidierte Heilmittelgesetz von beiden Räten nach einer Einigungskonferenz angenommen.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    New Regulations Regarding Drug Pricing

    In its decision of 14 December 2015, the Swiss Federal Supreme Court had confirmed that the practice of the Federal Office of Public Health (FOPH) which, in the course of the regular triennial review, determines the prices of drugs...
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    The Revision Of The Therapeutic Products Act Has Been Adopted

    The National Council and the Council of States have adopted the revised Therapeutic Products Act during the federal parliament's spring session of 2016.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Implementation Of Several Parts Of The Revised TPA And Pata As Well As Of The Therapeutic-Products-Ordinance-Package IV On 1 January 2019

    On 21 September 2019, the Federal Council decided to implement several parts of the amendments adopted in the spring session 2016 regarding the legislation ...
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Reproductive Medicine - Permissibility And Limits In Switzerland

    On 1 September 2017, the revised law on reproductive medicine and the revised reproductive medicine ordinance came into force in Switzerland
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    MLL Meyerlustenberger Lachenal Froriep Ltd
    MLL Meyerlustenberger Lachenal Froriep Ltd
  • Article

    A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

    In 2025, federal scrutiny of Pharmacy Benefit Managers (PBMs) has reached a level not seen before. What was once tolerated as opaque and self-serving practices is now the subject of a coordinated...
    SwitzerlandAccounting and Audit
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Consultation Opened On Amendments To Pharmaceutical Pricing

    Switzerland is moving ahead with the implementation of the Cost Containment Package 2: On 18 February 2026, the Federal Council opened the consultation on a third set of significant revisions...
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Partial Revision Of The Swiss Therapeutic Products Act – Package 3b (HMG 3b)

    Bär & Karrer, a Swiss law firm, provides comprehensive legal and business solutions. Contact their Zurich office for expert assistance with legal advice, business inquiries, and professional services tailored to your needs.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Grundsatzurteil Und Verordnungsrevisionen Betreffend Überprüfung Von Arzneimittelpreisen

    In einem Grundsatzentscheid vom 30. April 2015 hat das Bundesverwaltungsgericht entschieden, die bald fünfjährige Praxis des Bundesamts für Gesundheit (BAG)...
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Regulatory Framework For CBD Products In Switzerland

    According to the current regulatory set-up in Switzerland, it is permissible to sell and purchase cannabis products, as long as the THC level remains below 1%.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Loyens & Loeff
    Loyens & Loeff
  • Article

    Digital Agriculture: How Patents Help To Ensure Sustainable Food Security

    The European Patent Office (EPO) has launched a series of initiatives to measure and encourage innovation in digital agriculture across the EU.
    European UnionIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    Neue Regeln Für Die Festsetzung Der Medikamentenpreise

    Das Bundesgericht hatte mit Urteil vom 14. Dezember 2015 bestätigt, dass die Praxis des Bundesamts für Gesundheit (BAG), die Preise von Arzneimitteln der Spezialitätenliste (SL) bei der ordentlichen Dreijahresüberprüfung grundsätzlich nur im Vergleich mit den Auslandpreisen zu überprüfen, gegen das Krankenversicherungsgesetz (KVG) verstösst.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

    Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Freispruch für das Doping!

    Die heutige Dopingpolitik mit ihrer angeblichen Sorge um die Gesundheitsgefährdung von Spitzensportlern ist von Widersprüchen geprägt und möglicherweise verfassungswidrig.
    WorldwideMedia, Telecoms, IT, Entertainment
    Rihm Attorneys
    Rihm Attorneys
  • Article

    Life Sciences 2025

    Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Life Sciences 2025

    According to Swiss nomenclature, the term therapeutic products covers medicinal products as well as medical devices.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Life Sciences In Switzerland: Legal And Regulatory Overview

    Medicinal products are products of chemical or biological origin which are intended or claimed to have a medicinal effect on the human organism, in particular in the diagnosis, prevention or treatment of diseases...
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.
  • Article

    Life Sciences 2024

    Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.
    SwitzerlandFood, Drugs, Healthcare, Life Sciences
    Bär & Karrer Ltd.
    Bär & Karrer Ltd.

Showing 21–38 of 38 results

Previous